AnaptysBio(ANAB)
37.00 -0.06 -0.1619%
| 今开：37.32 | 昨收：37.06 |
| 最高：37.49 | 最低：36.61 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.010789828E9 |
AnaptysBio的热门讨论
持股变动声明
AnaptysBio(ANAB)06-19 17:25
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017509 Size: 7 KB 网页链接查看全文
持股变动声明
AnaptysBio(ANAB)06-19 17:25
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017512 Size: 7 KB 网页链接查看全文
持股变动声明
AnaptysBio(ANAB)06-19 17:25
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017510 Size: 7 KB 网页链接查看全文
超过5%股东持股披露
AnaptysBio(ANAB)07-10 22:15
$AnaptysBio(ANAB)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-24-001841 Act: 34 Size: 8 KB 网页链接查看全文
当期报告
AnaptysBio(ANAB)06-13 04:15
$AnaptysBio(ANAB)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001370053-24-000029 Act: 34 Size: 7 MB 网页链接查看全文
持股变动声明
AnaptysBio(ANAB)07-25 04:25
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020034 Size: 6 KB 网页链接查看全文
持股变动声明
AnaptysBio(ANAB)07-25 04:25
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020036 Size: 6 KB 网页链接查看全文
超过5%股东持股披露
AnaptysBio(ANAB)05-07 01:05
$AnaptysBio(ANAB)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-131732 Act: 34 Size: 464 KB 网页链接查看全文
持股变动声明
AnaptysBio(ANAB)06-19 17:25
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017508 Size: 7 KB 网页链接查看全文
持股变动声明
AnaptysBio(ANAB)06-19 17:25
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017507 Size: 8 KB 网页链接查看全文
AnaptysBio的最新讨论
![[怒了]](https://assets.imedao.com/ugc/images/face/emoji_08_angry.png?v=1 "[怒了]"){kind=small}
![[关灯吃面]](https://assets.imedao.com/ugc/images/face/emoji_19_noodles.png?v=1 "[关灯吃面]"){kind=small}
所以这个成本怎么计算。新靶点IL-33的II期临床数据极佳，AnaptysBio股价飙升101%
医药魔方2017-10-13 13:47
10月10日AnaptysBio（NASDAQ: ANAB）公布了anti-IL-33抗体ANB020治疗成人中度至重度特应性皮炎的IIa期临床结果，这也是针对IL-33的第一份proof-of-concept数据，单剂ANB020治疗后高达83%的患者实现EASI-50，AnaptysBio股价当即飙升101.17%，市值来到14亿美元。
白介素类靶点在自身免疫疾病上的...查看全文
淘沙见金2017-10-12 00:03
$AnaptysBio, Inc.(ANAB)$ 对比 $再生元制药(REGN)$ 的Dupixent, 人数少了一些不过结果相当不错。三期试验如果能复制这样的结果市值估计还得翻倍。不过最大的作用在于验证了IL-33这个靶点的作用，也增加了下半年的花生过敏症状的试验成功的几率。查看全文
淘沙见金2017-10-10 20:13
$AnaptysBio, Inc.(ANAB)$ AnaptysBio (NASDAQ:ANAB) is up 49% premarket on light volume in response to its announcement of positive results from a Phase 2 clinical trial assessing lead candidate ANB020 for the treatment of adults with moderate-to-severe atopic dermatitis (AD)...查看全文
Replix锐璞美股2017-09-19 11:25
$AnaptysBio, Inc.(ANAB)$ Replix生物医药研究员 @淘沙见金 挖掘的ANAB由研究时至今涨幅已超过45% （8月30日收盘价$25.77 - 9月18日盘中最高$37.75)，期待Replix生物医药研究给大家带来更精彩的医药股！@今日话题 @飞冲天@书呆老李 @翰泓@医药老庙 @bngdhpp @悦己2015查看全文
AnaptysBio-靶向IL-33单抗药物的价值
淘沙见金2017-08-30 11:53
*个人笔记为主，非分析类文章，欢迎讨论
抗体制药公司AnaptysBio $AnaptysBio, Inc.(ANAB)$ 主要开发治疗炎症的抗体。在研产品有：针对严重花生过敏和嗜酸性粒细胞性哮喘的IL-33抗体的ANB020和用于治疗脓疱性银屑病IL-36R抗体的ANB019。其中ANB020正处于临床2期，结果将在2017年下半年宣布。
AnaptysBio的公告
持股变动声明
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020034 Size: 6 KB 网页链接
持股变动声明
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020036 Size: 6 KB 网页链接
持股变动声明
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020039 Size: 6 KB 网页链接
持股变动声明
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-020031 Size: 6 KB 网页链接
持股变动声明
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019829 Size: 9 KB 网页链接
证券出售报告
$AnaptysBio(ANAB)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005507 Act: 33 Size: 4 KB 网页链接
持股变动声明
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019676 Size: 11 KB 网页链接
证券出售报告
$AnaptysBio(ANAB)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005377 Act: 33 Size: 5 KB 网页链接
超过5%股东持股披露
$AnaptysBio(ANAB)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-24-001841 Act: 34 Size: 8 KB 网页链接
持股变动声明
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018032 Size: 4 KB 网页链接